This comprehensive PRISMAP public event will include updates on PRISMAP activities and presentations by users on their research projects.
We are pleased to welcome six of our users who will present their innovative and original results, which were made possible by the support and provision of radionuclides by PRISMAP.
Further details on the user projects funded by PRISMAP can be found on the corresponding page of the PRISMAP website.
This is an online event.
| 8.30 | Reception | |||
| 9.00 | Welcome and news from PRISMAP | Thomas Cocolios | ||
| 9.15 | The absorbed dose – response relationship of Auger electrons from La-135 | Melissa Crabbé, SCK CEN (Belgium) | ||
| 9.45 | Antibody-based molecular radiotherapy: assessment of 161Tb-AKIR001 for potential treatment of CD44v6-positive cancer/td> | Marika Nestor, Uppsala University (Sweden) | ||
| 10.15 | [64Cu/67Cu]Radiolabelled exosomes as a theranostic tool for lung metastasis | Antero Abrunhosa, ICNAS Pharma / University of Coimbra (Portugal) | ||
| 10.45 | Short break | |||
| 11.00 | Delivering molecularly targeted radionuclide therapy to alleviate immune suppression in glioblastoma | Gabriela Kramer-Marek, The Institute of Cancer Research (UK) | ||
| 11.30 | Terbium Chelation for Nuclear Medicine | Michel Meyer, Université Bourgogne-Europe (FR) | ||
| 12.00 | Impact of Tb-156 pollution on image quality and quantitative accuracy of gamma camera imaging with Tb-155 | Mohammed Hussein, IJCLab (France) | ||
| 12.30 | End of the event | |||
The meeting can be attended online.